FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival (Q40090775)

17 September 2017

title

FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival (English)

1 reference

17 September 2017

2

1 reference

17 September 2017

Gjerdrum LM

1

1 reference

17 September 2017

Odum N

3

1 reference

17 September 2017

Burton CM

4

1 reference

17 September 2017

Rossen K

5

1 reference

17 September 2017

Skovgaard GL

6

1 reference

17 September 2017

Ryder LP

7

1 reference

17 September 2017

Ralfkiaer E

8

1 reference

17 September 2017

publication date

23 August 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

21

1 reference

17 September 2017

issue

12

1 reference

17 September 2017

page(s)

2512-2518

1 reference

Regulatory T cells, tumour immunity and immunotherapy

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

CD4+ CD25+ suppressor T cells: more questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Jak3- and JNK-dependent vascular endothelial growth factor expression in cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Real-time quantitative PCR of microdissected paraffin-embedded breast carcinoma: an alternative method for HER-2/neu analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Telomere length of in vivo expanded CD4(+)CD25 (+) regulatory T-cells is preserved in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

E-selectin, thymus- and activation-regulated chemokine/CCL17, and intercellular adhesion molecule-1 are constitutively coexpressed in dermal microvessels: a foundation for a cutaneous immunosurveillance system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

CD25+CD4+ T cells contribute to the control of memory CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Natural regulatory T cells: mechanisms of suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

A role for regulatory T cells in cutaneous T-Cell lymphoma; induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

7 January 2021

Fatal attraction: tumors beckon regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

7 January 2021

The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

7 January 2021

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

7 January 2021

CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

7 January 2021

The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

7 January 2021

Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

7 January 2021

Regulatory T-cell phenotype in association with large cell transformation of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404913

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404913

1 reference

Dimensions Publication ID

17 September 2017

1046758380

0 references

1 reference